Patanjali Ayurved's Acharya Balkrishna apologises in SC over misleading ads
Op IndiaPatanjali Ayurved Managing Director Acharya Balkrishna has tendered an unqualified apology in the Supreme Court over alleged misleading In an affidavit, Patanjali Ayurved Managing Director Acharya Balkrishna said that he submits an unqualified apology before the top court for the breach of the statement recorded in the order copy of the top court dated November 21, 2023. The affidavit came as a response to the SC’s earlier order, whereby the court sought from Patanjali Ayurveda Managing Director Acharya Balkrishna a response to the show cause notice in contempt proceedings against him over alleged misleading In the earlier hearing, the top court issued notice to Ayurvedic Company, asking it to show cause why contempt of action should not be initiated against the company and its managing director for giving misleading The top court had observed that the ayurvedic company has prima facie violated the top court’s order dated November 20, 2023, where it cautioned against misleading The court had also restrained the Ayurvedic Company from advertising or branding their products specified as treating disease under the drug norms and also cautioned it from making any statements against any system of medicine in the media. The court’s observation came when it noted that the company has given alleged misleading The court was dealing with an Indian Medical Association plea seeking to frame guidelines for prohibiting false and misleading IMA, a registered society, has more than 3,30,000 medical doctors as its members all over the country. IMA, in its plea, had sought to pass an order directing the Center and others to immediately take strict and prompt action, in accordance with law, for the violation of the provisions of the Drugs and Magic Remedies Act, 1954, the Drugs & Cosmetics Rules, 1945 and the Consumer Protection Act, 2019 by the repeated acts of omission and commission of Respondent Patanjali Ayurved Ltd., including by publishing